Lonial S - Search Results

1

Sequential or combination therapy for multiple myeloma.

Nooka A, Lonial S. Nooka A, et al. Among authors: lonial s. Expert Rev Hematol. 2012 Oct;5(5):533-45. doi: 10.1586/ehm.12.49. Expert Rev Hematol. 2012. PMID: 23146057 Review.

2

Breakthroughs in the management of multiple myeloma.

Heffner LT Jr, Lonial S. Heffner LT Jr, et al. Among authors: lonial s. Drugs. 2003;63(16):1621-36. doi: 10.2165/00003495-200363160-00001. Drugs. 2003. PMID: 12904084 Review.

3

Signal transduction and myeloma: new targets, new hope.

Lonial S, Waller EK, Simons JW, Heffner LT Jr. Lonial S, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4):310-9. doi: 10.4161/cbt.2.4.425. Cancer Biol Ther. 2003. PMID: 14508098 Free article. Review.

4

Multiple myeloma: the role of transplant and novel treatment strategies.

Kaufman J, Lonial S. Kaufman J, et al. Among authors: lonial s. Semin Oncol. 2004 Apr;31(2 Suppl 4):99-105. doi: 10.1053/j.seminoncol.2004.02.015. Semin Oncol. 2004. PMID: 15124142 Review.

5

Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activity.

Everly JJ, Lonial S. Everly JJ, et al. Among authors: lonial s. Expert Opin Biol Ther. 2005 Mar;5(3):293-311. doi: 10.1517/14712598.5.3.293. Expert Opin Biol Ther. 2005. PMID: 15833068 Review.

6

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma.

Lonial S, Waller EK, Richardson PG, Jagannath S, Orlowski RZ, Giver CR, Jaye DL, Francis D, Giusti S, Torre C, Barlogie B, Berenson JR, Singhal S, Schenkein DP, Esseltine DL, Anderson J, Xiao H, Heffner LT, Anderson KC; SUMMIT/CREST Investigators. Lonial S, et al. Blood. 2005 Dec 1;106(12):3777-84. doi: 10.1182/blood-2005-03-1173. Epub 2005 Aug 11. Blood. 2005. PMID: 16099887 Free PMC article. Clinical Trial.

7

The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is associated with down-regulation of p-AKT.

David E, Sun SY, Waller EK, Chen J, Khuri FR, Lonial S. David E, et al. Among authors: lonial s. Blood. 2005 Dec 15;106(13):4322-9. doi: 10.1182/blood-2005-06-2584. Epub 2005 Aug 23. Blood. 2005. PMID: 16118318 Free article.

8

Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004.

Haas M, Lonial S. Haas M, et al. Among authors: lonial s. Expert Opin Investig Drugs. 2005 Sep;14(9):1161-9. doi: 10.1517/13543784.14.9.1161. Expert Opin Investig Drugs. 2005. PMID: 16144500

9

Novel treatment approaches for patients with multiple myeloma.

Sinha R, Kaufman JL, Lonial S. Sinha R, et al. Among authors: lonial s. Clin Lymphoma Myeloma. 2006 Jan;6(4):281-8. doi: 10.3816/CLM.2006.n.002. Clin Lymphoma Myeloma. 2006. PMID: 16507205 Review.

10

Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.

Brinker BT, Waller EK, Leong T, Heffner LT Jr, Redei I, Langston AA, Lonial S. Brinker BT, et al. Among authors: lonial s. Cancer. 2006 May 15;106(10):2171-80. doi: 10.1002/cncr.21852. Cancer. 2006. PMID: 16598756 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters